 The FDA has approved Zoetis Incs NYSE: ZTS Solensia frunevetmab injection to control the pain of osteoarthritis OA in cats, helping improve their mobility, comfort, and overall well-being. Solensia, prescribed as a once-monthly injection administered in the veterinary clinic, controls OA pain by targeting Nerve Growth Factor NGF, a key driver in OA pain. 